- Patent Title: Methods for diagnosing a colorectal cancer (CRC) health state or change in CRC health state, or for diagnosing risk of developing CRC or the presence of CRC in a subject
-
Application No.: US15192522Application Date: 2016-06-24
-
Publication No.: US10697969B2Publication Date: 2020-06-30
- Inventor: Shawn Ritchie , Dayan Goodenowe
- Applicant: MED-LIFE DISCOVERIES LP
- Applicant Address: CA Saskatoon, Saskatchewan
- Assignee: MED-LIFE DISCOVERIES LP
- Current Assignee: MED-LIFE DISCOVERIES LP
- Current Assignee Address: CA Saskatoon, Saskatchewan
- Agency: Pepper Hamilton LLP
- Main IPC: G01N33/48
- IPC: G01N33/48 ; G01N33/50 ; G01N33/574 ; G01N33/82
Abstract:
The present invention relates to the diagnosis of colorectal and ovarian cancers (CRC and OC, respectively). The present invention describes the relationship between endogenous small molecules and CRC or OC. Specifically, the present invention relates to the diagnosis of CRC and OC through the measurement of vitamin E isoforms and related metabolites. The present invention also relates to diagnostic markers identified in said method. The present invention relates to the underlying case and pre-symptomatic phases of CRC, the diagnosis of various stages and severity of CRC, the early detection of CRC, monitoring and diagnosing the effect of therapy on CRC and OC health states.
Public/Granted literature
Information query
